(3S)-4-(4-hydroxyphenyl)-3-methylbutan-2-one | 169477-92-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (3S)-4-(4-hydroxyphenyl)-3-methylbutan-2-one
• CAS: 169477-92-3
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.23
• InChiKey: RKONDNYXZKXHAL-QMMMGPOBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• COLLAGEN BINDING PEPTIDES
  申请人：Caravan D. Peter

  公开号：US20070293656A1

  公开（公告）日：2007-12-20

  Peptides capable of binding to extracellular matrix proteins, such as collagen, are described, including their use in diagnostic and therapeutic applications.

  描述了能够结合到细胞外基质蛋白（如胶原蛋白）的肽段，包括它们在诊断和治疗应用中的用途。
• METHODS OF COLLAGEN IMAGING
  申请人：Caravan D. Peter

  公开号：US20080044360A1

  公开（公告）日：2008-02-21

  Diagnostic compositions and methods for imaging and/or assessing collagen are described. The diagnostic compositions can include collagen binding peptides.

  描述了用于成像和/或评估胶原蛋白的诊断组合物和方法。诊断组合物可以包括胶原结合肽。
• HPYY(1-36) Having a Beta-Homoarginine Substitution at Position 35
  申请人：NOVON NORDISK A/S

  公开号：US20160263197A1

  公开（公告）日：2016-09-15

  The invention relates to PYY compounds having the amino acid in the position corresponding to position 35 of hPYY(1-36) substituted with beta-homoarginine and derivatives thereof with a modifying group attached to the position corresponding to position 7 of hPYY(1-36). The compounds of the invention are selective Y2 receptor agonists. The invention also relates to pharmaceutical compositions comprising such PYY compounds and pharmaceutically acceptable excipients, as well as the medical use of the PYY compounds.

  该发明涉及PYY化合物，其中该氨基酸位于与hPYY(1-36)的第35位对应的位置上，被β-同型精氨酸及其衍生物取代，并且在与hPYY(1-36)的第7位对应的位置上连接有修饰基团。该发明的化合物是选择性Y2受体激动剂。该发明还涉及包括这种PYY化合物和药用可接受的赋形剂的药物组合物，以及PYY化合物的医药用途。
• METHODS OF MYOCARDIAL IMAGING
  申请人：Caravan D. Peter

  公开号：US20080058636A1

  公开（公告）日：2008-03-06

  Diagnostic compositions and methods for imaging collagen and/or assessing myocardial perfusion are described. The diagnostic compositions can include collagen binding peptides.

  本文描述了用于成像胶原蛋白和/或评估心肌灌注的诊断组合物和方法。诊断组合物可以包括胶原蛋白结合肽。
• Inhibitors of interleukin-1Beta converting enzyme
  申请人：VERTEX PHARMACEUTICALS INCORPORATED

  公开号：EP2123665A2

  公开（公告）日：2009-11-25

  The present invention relates to novel classes of compounds which are inhibitors of interleukin-1β converting enzyme. The ICE inhibitors of this invention are characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting ICE activity and consequently may be advantageously used as agents against interleukin-1 mediated diseases, including inflammatory diseases, autoimmune diseases and neurodegenerative diseases. This invention also relates to methods for inhibiting ICE activity and methods for treating interleukin-1 mediated diseases using the compounds and compositions of this invention.

  本发明涉及一类新型化合物，它们是白细胞介素-1β转换酶的抑制剂。本发明的 ICE 抑制剂具有特定的结构和理化特征。本发明还涉及包含这些化合物的药物组合物。本发明的化合物和药物组合物特别适用于抑制 ICE 的活性，因此可作为抗白细胞介素-1 介导的疾病（包括炎症性疾病、自身免疫性疾病和神经退行性疾病）的药物。本发明还涉及抑制 ICE 活性的方法以及使用本发明化合物和组合物治疗白细胞介素-1 介导的疾病的方法。